The combination of strong organic growth, margin expansion, and raised guidance suggests improving fundamentals. Traders should monitor the sustainability of CooperVision's premium product momentum and the company's ability to deliver on its increased free cash flow targets, which could support further share repurchases.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Mar 6 $76.36entry
- T+1 · 8mo ago −1.05%α −1.89% · $75.56
- T+5 · 8mo ago −8.59%α −7.06% · $69.80
- T+20 · 8mo ago −8.13%α −6.09% · $70.15
- T+60 · 6mo ago −21.18%α −33.96% · $60.19
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CooperCompanies reported strong first quarter 2026 results with revenue of $1.024 billion (up 6% YoY) and GAAP EPS of $0.66 (up 27% YoY), driven by growth in its CooperVision and CooperSurgical segments. The company raised its full-year 2026 guidance for non-GAAP EPS and free cash flow, citing strong profitability and cash generation.
Key Financial Metrics
Key Facts
- Q1 2026 revenue: $1.024 billion, up 6% YoY (3% organically)
- GAAP EPS: $0.66, up 27% YoY; Non-GAAP EPS: $1.10, up 20% YoY
- Raised full-year 2026 guidance: non-GAAP EPS of $4.58-$4.66 and free cash flow of $600-$625 million
- CooperVision revenue up 8% YoY; CooperSurgical revenue up 3% YoY
- Repurchased $92.5 million of stock in the quarter
Financial Impact
Revenue increased by $59.4 million and GAAP EPS increased by $0.14 per share compared to the prior year quarter
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| CooperVision | $695.1M | +8.0% |
| CooperSurgical | $329.0M | +3.0% |
Risk Factors
- Potential impact of tariffs on gross margin
- Integration and execution risks related to reorganization initiatives
- Foreign exchange rate fluctuations
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-015231 |
| Document: coo-20260305.htm | 0001628280-26-015231 |
| Document: 0001628280-26-015231-index-headers.html | 0001628280-26-015231 |
| Document: 0001628280-26-015231-index.html | 0001628280-26-015231 |
| Document: 0001628280-26-015231.txt | 0001628280-26-015231 |
Track record
10 reports on COO
2 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +7.83% at T+20 after the Jun 4, 2026 report. 2 of 5 went positive at some point.
Filters
- Oct 27, 202620d ago 8-K Bearish 6/10 Entry $59.41 Now $61.88 −4.16% settles Nov 25
- Oct 15, 20264w ago Institutional Cluster Bearish 4/10 Entry $57.40 to $62.93 Now $61.88 −7.80% ▼ −9.63% −11.05% vs SPY
- Sep 17, 20268w ago Insider Cluster Bullish 4/10 Entry $55.29 to $57.94 Now $61.88 +11.92% ▲ +4.79% +4.59% vs SPY
- Sep 15, 20268w ago Insider Cluster Neutral 2/10 Entry $54.61 to $54.88 Now $61.88 +13.31% ▲ +0.49% −1.57% vs SPY
- Sep 9, 20269w ago Press Release Mixed 6/10 Entry $54.17 to $54.30 Now $61.88 +14.23% ▲ +0.24% −1.88% vs SPY
- Jun 4, 202623w ago 8-K Mixed 6/10 No price data
- Jun 4, 202623w ago Press Release Bullish 6/10 Entry $67.34 to $72.61 Now $61.88 −8.11% ▲ +7.83% +5.96% vs SPY
- Mar 5, 202636w ago 8-K Bullish 8/10 Viewing Entry $76.36 to $70.15 Now $61.88 −18.97% ▼ −8.13% −6.09% vs SPY
- Mar 5, 202636w ago Press Release Bullish 8/10 Entry $76.36 to $70.15 Now $61.88 −18.97% ▼ −8.13% −6.09% vs SPY
- Feb 24, 202637w ago DEFA14A Neutral 2/10 Entry $83.38 to $71.35 Now $61.88 −25.79% ▼ −14.43% −9.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers